Cellaria’s new stem cell division will provide RNA reprogramming and differentiation services in a comprehensive yet modular workflow. The company’s initial reprogramming focus will be on custom solutions for primary cell establishment, induced pluripotent stem cell (iPSC) generation, banking and characterization. Cellaria will also offer customizable differentiation services for various cell types, such as neurons, hepatocytes and skeletal muscle.

 

Cellaria’s reprogramming platform will enable access to a broad set of patient cells, including cells derived from human skin and blood, for the development of the next generation of disease models. With the addition of an extremely flexible and tailored differentiation system, Cellaria provides a single-source solution to stem cell services.

 

Cellaria Bio